[Guidelines for ambulatory monitoring of kidney transplant patients. Adaptation of the Guidelines of the American Society of Transplantation (J Am Soc Nephrol 2000; 11 (S1): 86)].
Fuiano
G
G
Zoccali
C
C
Bertoni
E
E
Bartolomeo
F
F
Cambareri
F
F
Salvadori
M
M
Altieri
P
P
Ponticelli
C
C
Sandrini
S
S
Schena
F P
FP
Segoloni
G P
GP
Stefoni
S
S
D000208:Acute Disease; D001424:Bacterial Infections / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D006084:Graft Rejection / Q000175:diagnosis / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007558:Italy; D007668:Kidney / Q000503:physiopathology*; D016030:Kidney Transplantation / Q000009:adverse effects*; D018670:Monitoring, Ambulatory / Q000379:methods / Q000592:standards; D009369:Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D015596:Nutrition Assessment; D011086:Polycythemia / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D011507:Proteinuria / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D014481:United States; D014777:Virus Diseases / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control
D007166:Immunosuppressive Agents